Puma Biotechnology Inc (PBYI)
$10.44 -0.95% Close Oct 30, 2026 Live
Puma Biotechnology stock today
Puma Biotechnology closed at $10.44 on October 30, 2026, down 0.95% on the day. Over the past year it returned +91.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $531 million.
$6.00$8.00$10.00
NovJan 2026MarMayJulSep
| Period | PBYI | S&P 500 (SPY) |
|---|---|---|
| 1 month | +5.1% | -0.9% |
| 3 months | +32.3% | +2.1% |
| Year to date | +75.5% | +11.7% |
| 1 year | +91.2% | +12.4% |
| 3 years | +315.9% | +88.5% |
| 5 years | +104.7% | +76.0% |
Key statistics
- Market value
- $531M
- P/E (trailing)
- 20.1
- Price / sales
- 2.3
- 52-week range
- $4.73 to $11.26
- Next report
- Nov 5, 2026
About Puma Biotechnology
Develops and commercializes oncology and targeted cancer treatment pharmaceuticals.
Sector: Health Care
More on Puma Biotechnology
- Financials: revenue, earnings and segmentsRevenue -1% in the year to Dec 2025
- Valuation: P/E history and peersP/E 20.1, median 9.6 at its last 3 year ends
- Returns: what $1,000 became$1,000 ten years ago is $265.99 today
No forecast, no recommendation. This page describes Puma Biotechnology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.